Fujian Wanchen Biotechnology Group Co., Ltd. (SHE:300972)
China
· Delayed Price · Currency is CNY 155.79
+4.59 (3.04%)
At close: May 13, 2025, 2:57 PM CST
SHE:300972 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 502.14 | 293.52 | -82.93 | 47.74 | 23.45 | 96.13 | Upgrade
|
| Depreciation & Amortization | 264.15 | 264.15 | 182.32 | 64.48 | 61.32 | 59.61 | Upgrade
|
| Other Amortization | 17.01 | 17.01 | 9.78 | 1 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 8.34 | 8.34 | 3.26 | 1.66 | 0.49 | 0.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 11 | 11 | 4.04 | 0.31 | 0.1 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0 | -0 | -0.06 | -1.72 | -1.8 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 3.39 | 3.39 | 4.95 | 0.78 | 0.05 | 0.01 | Upgrade
|
| Other Operating Activities | 603.49 | 373.79 | -26.99 | -1.99 | 5.18 | 8.48 | Upgrade
|
| Change in Accounts Receivable | -817.08 | -817.08 | -338.41 | -53.22 | -7.39 | 0.33 | Upgrade
|
| Change in Inventory | -1,420 | -1,420 | -635.44 | -44.73 | -4.57 | -9.16 | Upgrade
|
| Change in Accounts Payable | 1,900 | 1,900 | 1,754 | 54.56 | 22 | 0.7 | Upgrade
|
| Change in Other Net Operating Assets | 219.37 | 219.37 | 147.97 | 1.48 | - | - | Upgrade
|
| Operating Cash Flow | 1,287 | 848.35 | 1,023 | 70.38 | 98.82 | 156.24 | Upgrade
|
| Operating Cash Flow Growth | 1.35% | -17.08% | 1353.60% | -28.78% | -36.75% | -11.87% | Upgrade
|
| Capital Expenditures | -110.59 | -116.65 | -218.91 | -316.34 | -41.57 | -56.1 | Upgrade
|
| Sale of Property, Plant & Equipment | 19.62 | 20.44 | 17.55 | 0.36 | 0.37 | 0.2 | Upgrade
|
| Cash Acquisitions | - | - | -5.4 | - | - | - | Upgrade
|
| Investment in Securities | - | - | 0.06 | 20 | -18.23 | - | Upgrade
|
| Other Investing Activities | 0.22 | 0 | - | 1.76 | - | - | Upgrade
|
| Investing Cash Flow | -90.76 | -96.21 | -206.69 | -294.22 | -59.43 | -55.9 | Upgrade
|
| Long-Term Debt Issued | - | 1,106 | 613.22 | 265.97 | 90.7 | 88 | Upgrade
|
| Long-Term Debt Repaid | - | -752.14 | -396.64 | -114.49 | -175.35 | -129.86 | Upgrade
|
| Net Debt Issued (Repaid) | 346.66 | 353.84 | 216.58 | 151.47 | -84.65 | -41.86 | Upgrade
|
| Issuance of Common Stock | 103.8 | 298.8 | 9.45 | - | 245.42 | - | Upgrade
|
| Common Dividends Paid | -70.17 | -29.96 | -15.15 | -39.22 | -5.23 | -49.01 | Upgrade
|
| Dividends Paid | -70.17 | -29.96 | -15.15 | -39.22 | -5.23 | -49.01 | Upgrade
|
| Other Financing Activities | -307.82 | -319.22 | 11.39 | 10.41 | -12.26 | -3.08 | Upgrade
|
| Financing Cash Flow | 72.47 | 303.46 | 222.26 | 122.66 | 143.28 | -93.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | -0 | -0 | - | - | -0 | Upgrade
|
| Net Cash Flow | 1,268 | 1,056 | 1,039 | -101.17 | 182.67 | 6.39 | Upgrade
|
| Free Cash Flow | 1,176 | 731.69 | 804.17 | -245.96 | 57.25 | 100.14 | Upgrade
|
| Free Cash Flow Growth | 13.59% | -9.01% | - | - | -42.83% | -27.20% | Upgrade
|
| Free Cash Flow Margin | 3.07% | 2.26% | 8.65% | -44.78% | 13.17% | 22.25% | Upgrade
|
| Free Cash Flow Per Share | 6.05 | 3.91 | 5.23 | -1.58 | 0.41 | 0.88 | Upgrade
|
| Cash Income Tax Paid | 885.02 | 642.9 | 93.11 | 9.01 | 3.49 | 2.98 | Upgrade
|
| Levered Free Cash Flow | 1,060 | 748.19 | 912.09 | -256.14 | 40.51 | 34.82 | Upgrade
|
| Unlevered Free Cash Flow | 1,095 | 779.97 | 930.05 | -253.51 | 43.74 | 39.54 | Upgrade
|
| Change in Net Working Capital | 159.09 | 220.18 | -837.84 | 22.73 | -16.07 | 26.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.